Modeling the asymptomatic prevalence of SARS-CoV-2 epidemic in Italy and the ISTAT survey
Preprint
Abstract
objectives August 3rd, 2020, the Italian National Institute of Statistics (ISTAT) presented preliminary results of seroprevalence survey on the percentage of individuals affected by Covid-19. The survey aims to define (within the entire population of Italy) the portion of individuals that developed an antibody response against SARS-CoV-2. For the first time one has an estimate of the asymptomatic infected population and the possibility to acknowledge its potential rôle in the infection spread in Italy, one of the most affected areas in Europe. The information obtained allow a particularly sensitive validation of epidemiological models which include the asymptomatic class. methods The present study is devoted to the construction of a model able to simulate, in a systematic way, the asymptomatic group whose relevance in the, SARS-CoV-2 epidemic, has been recently investigated and discussed. The investigation involves the description of the first epidemic outbreak in Italy as well as the predictive analysis of the ongoing second wave. In particular the possible correction to the data of the serological tests because of their sensitivity and specificity. results The model: taken as an example of the models presently used, satisfactory reproduces the data of the ISTAT survey showing a relevant predictive power and relegating in a secondary position models which do not include, in the simulation, the presence of asymptomatic groups. The corrections due to the serological test sensitivity (in particular those ones depending on the symptoms onset) make the comparison between data and models less accurate. conclusions The predictions of the model confirm a relevant presence of asymptomatic individuals also during the second pandemic wave in Italy. The ratio of reported to unreported cases is predicted to be roughly 1:4. A more detailed knowledge of the results of the survey could allow to correct, in a relevant way, the data by means of the experimental evidences on the antibodies sensibility. The model analyses of the vaccination strategies, confirms the relevance of a massive administration with the beginning of the year to arrive at the end of the infection within August 2021.Keywords
This publication has 41 references indexed in Scilit:
- Serological tests facilitate identification of asymptomatic SARS‐CoV‐2 infection in Wuhan, ChinaJournal of Medical Virology, 2020
- COVID-19 and Italy: what next?The Lancet, 2020
- Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian villageBMJ, 2020
- Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020Eurosurveillance, 2020
- Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health InterventionsJournal of Clinical Medicine, 2020
- An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov)Infectious Disease Modelling, 2020
- Data Analysis Recipes: Using Markov Chain Monte Carlo*The Astrophysical Journal Supplement Series, 2018
- A model for the emergence of drug resistance in the presence of asymptomatic infectionsMathematical Biosciences, 2013
- Handbook of Markov Chain Monte Carlo2011
- Post-Stratification: A Modeler's PerspectiveJournal of the American Statistical Association, 1993